Nitric oxide and the etiology of chronic fatigue syndrome: Giving credit where credit is due [10]

Medical Hypotheses

Volumn 65, Issue 3, 2005, Pages 631-633

  Pall, Martin L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXOCOBALAMIN; NITRIC OXIDE; ORGANOPHOSPHATE PESTICIDE; PEROXYNITRITE; PESTICIDE;

BACTERIAL INFECTION; BIOCHEMISTRY; CHRONIC FATIGUE SYNDROME; ENVIRONMENTAL EXPOSURE; HUMAN; INJURY; LETTER; MEDICAL LITERATURE; MENTAL STRESS; ORGANIZATION; PRIORITY JOURNAL; STRESS; VIRUS INFECTION;

EVIDENCE-BASED MEDICINE; FATIGUE SYNDROME, CHRONIC; HUMANS; NITRIC OXIDE;

EID: 22044442395     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.03.026     Document Type: Letter

References (19)

1. M.L. Pall Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome Med Hypotheses 54 2000 115 125
2. M.L. Pall Elevated peroxynitrite as the cause of chronic fatigue syndrome: other inducers and mechanisms of symptom generation J Chronic Fatigue Syndr 7 4 2000 45 58
3. M.L. Pall Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite Med Hypotheses 57 2001 139 145
4. M.L. Pall, and J.D. Satterlee Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome and posttraumatic stress disorder Ann NY Acad Sci 933 2001 323 329
5. M.L. Pall NMDA sensitization and stimulation by peroxynitrite, nitric oxide and organic FASEB J 16 2002 1407 1417
6. M.L. Pall Elevated nitric oxide/peroxynitrite theory of multiple chemical sensitivity: central role of N-methyl-d-aspartate receptors in the sensitivity mechanism Environ Health Perspect 111 2003 1461 1464
7. Pall ML, Anderson JH. The vanilloid receptor as a putative target of diverse chemicals in multiple chemical sensitivity. Arch Environ Health, in press.
8. M.L. Pall Cobalamin used in chronic fatigue syndrome therapy is a nitric oxide scavenger J Chronic Fatigue Syndr 8 2 2001 39 44
9. M.L. Pall Levels of the nitric oxide synthase product citrulline are elevated in sera of chronic fatigue syndrome patients J Chronic Fatigue Syndr 10 3/4 2002 37 41
10. I.V. Smirnova, and M.L. Pall Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients Mol Cell Biochem 248 2003 93 95
11. M.L. Pall Chronic fatigue syndrome/myalgic encepha (lo)myelitis Br J Gen Pract 52 2002 762
12. J. Nijs, and K. De Meirleir Oxidative stress might reduce fatty acids in erythrocyte memebranes of chronic fatigue syndrome patients Nutr Neurosci 7 2004 251 253
13. J. Nijs, K. De Meirleir, M. Meeus, N.R. McGregor, and P. Englebienne Chronic fatigue syndrome: intracellular immune deregulations as a possible etiology for abnormal exercise response Med Hypotheses 62 2004 759 765
14. J. Nijs, B. Van de Velde, and K. De Meirleir Pain in patients with chronic fatigue syndrome: does nitric oxide trigger central sensitization? Med Hypotheses 64 2005 558 562
15. P. Englebienne D.e. Meirleir Chronic fatigue syndrome: a biological approach 2002 CRC Press Boca Raton (FL)
16. J. Kanner, S. Harrel, and R. Granit Nitric oxide as an antioxidant Arch Biochem Biophys 289 1991 130 136
17. B.H. Natelson, and G. Lange A status report on chronic fatigue syndrome Environ Health Perspect 110 Suppl 4 2002 673 677
18. R. Patarca-Montero The concise encyclopedia of fibromyalgia and myofascial pain 2002 Haworth Medical Press New York
19. K. de Meirleir, C. Bisbal, I. Campine, P. De Becker, T. Salehzada, and E. Demettre A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome Am J Med 108 2000 99 105